Recent News

• 06.04.2025 - Jefferies Global Healthcare Conference
• 06.04.2025 - Jefferies Global Healthcare Conference
• 05.29.2025 - Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference
• 05.29.2025 - Stoke Therapeutics to Present at the Jefferies Global Healthcare Conference
• 05.13.2025 - Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
• 05.13.2025 - Stoke Therapeutics Reports First Quarter 2025 Financial Results and Provides Business Updates
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.08.2025 - 24th Annual Needham Virtual Healthcare Conference
• 04.01.2025 - Stoke Therapeutics to Present at the 24th Annual Needham Virtual Healthcare Conference

Recent Filings

• 05.13.2025 - 10-Q Quarterly report [Sections 13 or 15(d)]
• 05.13.2025 - EX-99.1 EX-99.1
• 05.13.2025 - 8-K Current report
• 05.05.2025 - 4 Statement of changes in beneficial ownership of securities
• 05.01.2025 - 144 Report of proposed sale of securities
• 04.22.2025 - DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material
• 04.22.2025 - DEF 14A Other definitive proxy statements
• 04.22.2025 - ARS Annual Report to Security Holders
• 04.16.2025 - SCHEDULE 13G/A Statement of Beneficial Ownership by Certain Investors
• 04.15.2025 - SCHEDULE 13G Statement of Beneficial Ownership by Certain Investors